Table 2.
Components | HCs vs. AIHp | HCs vs. PBCp | AIHp vs. PBCp | AIHp vs. PBCp vs. HCs | ||||
---|---|---|---|---|---|---|---|---|
N | Description | Mann—Whitney | Mann—Whitney | Mann—Whitney | Kruskal—Wallis | |||
p-Value | Change | p-Value | Change | p-Value | Change | p-Value | ||
1 | S100A12 | <0.05 | PBC > AIH | <0.05 | ||||
2 | S100A8 | |||||||
3 | S100A7D27 | <0.05 | PBC > AIH | <0.01 | ||||
4 | S100A9_short | |||||||
5 | S100A9_short_ox | <0.05 | C > PBC | <0.05 | ||||
6 | S100A9_short_P | <0.05 | ||||||
7 | S100A9_short_P_ox | |||||||
8 | Sum_S100A9_short_and_ox | |||||||
9 | Sum_S100A9_s_and_s_P | |||||||
10 | Sum_S100A9_s_P_and_P_ox | |||||||
11 | Sum_S100A9_s_ox_and_P_ox | <0.05 | C > PBC | <0.05 | ||||
12 | Sum_S100A9_short | <0.05 | C > PBC | |||||
13 | S100A9_long_g | |||||||
14 | S100A9_long_g_p | |||||||
15 | S100A9_long_g_ox | <0.05 | ||||||
16 | Sum_S100A9_long_g | |||||||
17 | Cystatin_A | <0.05 | AIH > C | <0.05 | AIH > PBC | <0.05 | ||
18 | Cystatin_A_Acetyl | |||||||
19 | Cystatin_A_Acetyl_T96L | |||||||
20 | Sum_Cystatin_A | <0.05 | AIH > C | |||||
21 | Cystatin_B_S_glut | |||||||
22 | Cystatin_B_S_cyst | |||||||
23 | Cystatin_B_SSdimer | |||||||
24 | Cystatin_B_S_CMC | |||||||
25 | Sum_Cystatin_B | |||||||
26 | Cystatin_C | <0.05 | PBC > C | <0.01 | ||||
27 | Cystatin_D_des_1_5 | |||||||
28 | Cystatin_S | |||||||
29 | Cystatin_S1 | <0.001 | PBC > C | <0.01 | PBC > AIH | <0.001 | ||
30 | Cystatin_S2 | <0.0001 | PBC > C | <0.01 | PBC > AIH | <0.0001 | ||
31 | Cystatin_SN | <0.01 | PBC > C | <0.05 | PBC > AIH | <0.05 | ||
32 | Cystatin_SN_des_1_4 | |||||||
33 | Cystatin_SA | |||||||
34 | Cystatin_S1_ox | <0.001 | AIH > C | <0.01 | ||||
35 | Cystatin_S2_ox | |||||||
36 | Cystatin_SN_ox | |||||||
37 | Sum_Cystatin_S1 | <0.0001 | PBC > C | <0.01 | PBC > AIH | <0.0001 | ||
38 | Sum_Cystatin_S2 | <0.0001 | PBC > C | <0.01 | PBC > AIH | <0.0001 | ||
39 | Sum_Cystatin_S_S1_S2 | <0.0001 | PBC > C | <0.001 | PBC > AIH | <0.0001 | ||
40 | Sum_Cystatin_SN | <0.01 | PBC > C | <0.05 | ||||
41 | Sum_Cystatin_SA | |||||||
42 | Hst_1 | |||||||
43 | Hst_1_0P | |||||||
44 | Sum_Hst_1 | |||||||
45 | Hst_6 | <0.01 | AIH > C | <0.05 | AIH > PBC | |||
46 | Hst_5 | <0.05 | AIH > C | <0.05 | AIH > PBC | <0.05 | ||
47 | Hst_3 | <0.05 | AIH > C | <0.01 | AIH > PBC | <0.01 | ||
48 | Sum_Hst_3 | <0.01 | AIH > C | <0.05 | AIH > PBC | <0.05 | ||
49 | Sum_Hst | <0.05 | AIH > C | <0.05 | ||||
50 | α_defensin_1 | |||||||
51 | α_defensin_2 | |||||||
52 | α_defensin_3 | |||||||
53 | α_defensin_4 | |||||||
54 | Sum_α_defensins | |||||||
55 | PRP1_2P | <0.05 | AIH > PBC | |||||
56 | PRP1_1P | |||||||
57 | PRP1_0P | |||||||
58 | PRP1_3P | <0.01 | PBC > C | <0.05 | ||||
59 | Sum_PRP1 | <0.05 | AIH > PBC | |||||
60 | PRP3_2P | |||||||
61 | PRP3_1P | <0.05 | C > PBC | <0.05 | AIH > PBC | <0.05 | ||
62 | PRP3_0P | |||||||
63 | PRP_3_diphos_Des_Arg106 | <0.05 | PBC > AIH | <0.05 | ||||
64 | Sum_PRP3 | |||||||
65 | P_C_peptide | |||||||
66 | Statherin_2P | <0.05 | AIH > C | |||||
67 | Statherin_1P | <0.05 | AIH > C | <0.05 | AIH > PBC | |||
68 | Statherin_0P | |||||||
69 | Sum_Statherin | <0.05 | AIH > C | |||||
70 | PB_peptide | <0.01 | AIH > PBC | <0.05 | ||||
71 | SLPI | <0.05 | PBC > C | <0.05 |